Related Experiment Videos
Summary
Giant cell arteritis can cause blindness, even with treatment. Early diagnosis and high-dose corticosteroid therapy are crucial for preventing vision loss in patients over 50.
Area of Science:
- Vascular Inflammation
- Rheumatology
- Ophthalmology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting medium and large arteries.
- It commonly involves the cranial arteries and can lead to serious complications like vision loss.
Observation:
- A 65-year-old woman presented with intermittent blindness.
- Angiography revealed severe atherosclerotic changes and radiographic evidence of arteritis.
- A temporal artery biopsy confirmed giant cell arteritis.
Findings:
- Despite high-dose corticosteroid treatment, the patient experienced irreversible blindness.
- Elevated Westergren sedimentation rate (>40 mm/hr) in patients over 50 with relevant symptoms is highly suggestive of GCA.
- Angiography can aid in diagnosis and biopsy site selection.
Implications:
- Prompt diagnosis and aggressive treatment with high-dose prednisone are critical to prevent vision loss in GCA.
- This case highlights the potential for severe outcomes despite treatment, emphasizing the need for timely intervention.
- Multidisciplinary approaches involving rheumatology and ophthalmology are essential for managing GCA effectively.